Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods of identifying modulators of gpr17

a modulator and modulator technology, applied in the field of methods of identifying modulators of gpr17, can solve the problems of low reported affinity of 5-ala and pbg, unsuitable for routine screening assays or even high throughput screening, and impracticality in routine handling, etc., to achieve significant superiority over published gpr17 agonists, high specificity and potency, and high affinity and selectivity

Active Publication Date: 2013-03-07
UNIVERSITY OF BONN
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes the discovery of a new compound, RA-II-150, and other compounds that activate GPR17, a receptor in the body. These compounds were found to be effective in a variety of cell lines, including those that lack GPR17, and were found to be agonists for GPR17 even in the absence of other compounds. The patent text also describes the structure of these compounds and their potential use in treating diseases that are influenced by GPR17, such as inflammation and pain.

Problems solved by technology

However, the reported affinity of 5-ALA and PBG is quite low and the amounts needed in the assays are significant, namely in the three digit micromolar range for 5-ALA or even in the mM range for PBG, which make both compounds not well suited for use in routine screening assays or even high throughput screenings.
Moreover, PBG is a chemical unstable, reactive compound which rapidly decomposes after exposure to air and light, making it impractical to handle on a routine basis.
However, these compounds have not yet been described as GPR17 modulators.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of identifying modulators of gpr17
  • Methods of identifying modulators of gpr17
  • Methods of identifying modulators of gpr17

Examples

Experimental program
Comparison scheme
Effect test

examples

Example (1)

hGPR17 Expressing Cell Systems And Media

[0162]The sequence for the human GPR17 (short isoform) was subcloned into the vector pLXSN (Clontech Laboratories, CA 94043, USA), which can be used for retroviral transfection of the human astrocytoma cell line 1321N1. Since it was postulated by Ciana et. al. that GPR17 is activated by uracil nucleotides such as UDP, UDP-glucose and UDP-galactose, 1321N1 astrocytoma cells were chosen as an appropriate test system, because it was known that this cell line does not express endogenous nucleotide receptors. For the retroviral transfection of 1321N1 astrocytoma cells the packaging cell line GP+envAM12 was cultivated in HXM medium (50 ml of foetal calf serum (FCS), 5 ml of penicillin G / streptomycin solution (final concentration 100 U / ml penicillin, 100 μg / ml streptomycin), 1% ultra glutamine, 0.75 ml of hypoxanthine (10 mg / ml), 12.5 ml of xanthine (10 mg / ml), 1.25 ml of mycophenolic acid (10 mg / ml) and 2 ml of hygromycin B (50 mg / ml) wer...

example

(4)

Description of 35SGTPYS Binding Assay

[0168][35S]GTPγS binding experiments were carried out in 96-well plates using 5 μg of protein / well. Membranes were added to 400 μl of incubation buffer (10 mM HEPES, 10 mM MgCl2, 100 mM NaCl, pH 7.4) containing 10 μM GDP and RA-II-150 in the indicated concentrations. Reactions were started by adding 50 μl of 0.07 nM [35S]GTPγS and then incubated for 60 min at 30° C. Membrane-bound radioactivity was separated by vacuum filtration. After drying, glass fiber filter mats were melted with scintillation wax, and radioactivity was measured by liquid scintillation counting.

example 5

β-Arrestin Assay

[0169]Arrestin recruitment was detected in BRET2 assays using HEK293 cells stably expressing human GPR17—Rluc and GFP2-β-arrestin2.

[0170]Cells were detached by trypsinization, counted and washed once in assay buffer (HBSS, 20 mM HEPES (S12), pH 7.0). After centrifugation at 800 rpm for 4 min, the pelleted cells were resuspended in an appropriate volume of assay buffer to a density of 1×106 cells per ml. In order to stabilize readings, cells were allowed to incubate at 28° C. for 30 min while slowly shaking (180 rpm), prior to experiments.

[0171]The coelenterazine 400A stock solution was freshly diluted (3:100) in PBS containing 20% of ethanol to obtain a 30 μM solution, which was always kept in the dark, due to its light-sensitivity.

[0172]As a first step, the agonist solutions were prepared and 10 μl of each 8-fold dilution was dispensed in the 384-well assay plate. DMSO concentrations were adjusted and did not exceed 0.1% in final concentrations.

[0173]Harvested and s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is related to a method of determining a test compound's ability to modify the biological activity of a GPR17. Said method comprises, among others, the step of contacting the test compound with a GPR17, or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I.

Description

BACKGROUND[0001]G-protein coupled receptors (GPCRs) constitute the largest family of membrane receptors in the cell. They transduce extracellular signals to intracellular effector systems and are involved in a large variety of physiological phenomena, therefore representing the most common target of pharmaceutical drugs although only a small percentage of GPCRs are targeted by current therapies.[0002]GPCRs respond to a wide range of ligands. Due to the progress of human genome sequencing, for about 25% out of the more than 400 GPCRs (not including the olfactory GPCRs) that have been identified, a defined physiologically relevant ligand is still lacking. These receptors are known as “orphan GPCRs”. “Deorphanization” and identification of their in vivo roles is expected to clarify novel regulatory mechanisms and, therefore, to disclose novel drug targets. Whether GPR17 is such an orphan receptor is still a matter of debate. Phylogenetically, GPR17 is most closely related to the nucleo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/405G01N33/567G01N21/75A61P9/00C07D405/10C07D409/10A61P9/10A61P25/00C12Q1/02C07D209/42
CPCA61K31/405C07K14/723C07D209/42G01N33/5041G01N33/6896G01N33/74C07D409/04G01N2500/00G01N2800/285G01N2800/2871C12Q1/025G01N33/566C07D405/04G01N2333/4719A61P25/00A61P9/00A61P9/10
Inventor KOSTENIS, EVISPINRATH, ANDREASHENNEN, STEPHANIEPETERS, LUCASMULLER, CHRISTA E.AKKARI, RHALIDBAQI, YOUNISRITTER, KIRSTEN
Owner UNIVERSITY OF BONN